Changing the Standard of Care in Prostate Cancer with Advances in Nuclear Medicine, PET and Theranostics Symposium - Rob Flavell

November 3, 2020

Prostate Cancer Outreach Webinar - Hosted by The Society of Nuclear Medicine and Molecular Imaging (SNMMI)'s Prostate Cancer Working Group, and faculty from the University of California, San Francisco (UCSF)

Molecular imaging and radionuclide therapies play an important role in the management of patients with prostate cancer. Recent advances are allowing for increased precision in both diagnosis and treatment. Join Robert Flavel, Tom Hope, Hao Nguyen, Felix Feng, and Rahul Aggarwal as they discuss this free webinar sharing the most up-to-date nuclear medicine technologies and procedures and their role in managing patients. Targeted for nuclear medicine physicians, pharmacists, technologists, physicists, and residents/students. At the completion of this video webinar, listeners will be able to review both standards of care and cutting-edge next-generation PET imaging methods for staging and restaging of prostate cancer, discuss the field of theranostics and radioligand therapy, where imaging can help select patients for appropriate therapies, and discuss how next-generation imaging approaches can be used to guide management in prostate cancer.

Welcome Overview: Robert Flavell
2:10 Thomas Hope: Introduction to PSMA PET
16:20 Hao Nguyen: Managing High-Risk Prostate Cancer: Integrating PSMA-based fluorescence molecular imaging during robotic prostatectomy
30:40 Felix Feng: Management of Oligometastatic Prostate Cancer: From Imaging to Therapy
48:20 Rahul Aggarwal: PSMA-Based Diagnostic and Theranostic Strategies in Metastatic Prostate Cancer
1:10:15 Question and Answer


Tom Hope, MD, Associate Professor, Director of Molecular Therapy, Radiology and Biomedical Imaging, University of California, San Francisco

Hao Nguyen, MD, Ph.D., Associate Professor, Goldberg-Benioff Endowed Professor in Cancer Biology, Urology, University of California, San Francisco

Felix Feng, MD, Professor, Vice-Chair for Translational Research, Radiation Oncology, Urology, and Medicine, University of California, San Francisco

Rahul Aggarwal, MD, Associate Professor in Hematology-Oncology, Associate Director of Clinical Research, HDFCCC, University of California, San Francisco

Rob Flavell, MD, Ph.D., Assistant Professor, Section Chief, Molecular Imaging and Therapeutics, Radiology and Biomedical Imaging, University of California, San Francisco.